Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 5Recruiting 3Not yet recruiting 3Withdrawn 2Terminated 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2CNS 1

Conditions

Thyroid Neoplasms 1Hypothyroidism 1Brain Neoplasms 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × OTHER × Thyroxine × Clear all
NCT02946918 2020-12-01

Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy

University of Texas Southwestern Medical Center

Phase 4 Terminated
14 enrolled 9 charts
Head & Neck

Thyroid Neoplasms

NCT00488644 2013-06-24

Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors

M.D. Anderson Cancer Center

Phase NA Terminated
12 enrolled 3 charts
CNSHead & Neck

Brain Neoplasms, Hypothyroidism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡